We are live on ! Find out more
ZNTL icon

Zentalis Pharmaceuticals
ZNTL

139 hedge funds and large institutions have $3.58B invested in Zentalis Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 53 increasing their positions, 33 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

623% more call options, than puts

Call options by funds: $10.9M | Put options by funds: $1.51M

500% more funds holding in top 10

Funds holding in top 10: 1 → 6 (+5)

171% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 14

61% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 33

32% more capital invested

Capital invested by funds: $2.71B → $3.58B (+$865M)

20% more funds holding

Funds holding: 116 → 139 (+23)

3.31% more ownership

Funds ownership: 91.57% → 94.88% (+3.3%)

Holders
139
Holders Change
+23
Holders Change %
+19.83%
% of All Funds
2.14%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.09%
New
38
Increased
53
Reduced
33
Closed
14
Calls
$10.9M
Puts
$1.51M
Net Calls
+$9.43M
Net Calls Change
-$19M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$50.5M
2
PA
Perceptive Advisors
New York
+$33.3M
3
Fiera Capital (Canada)
Fiera Capital (Canada)
Quebec, Canada
+$28.5M
4
APM
Avidity Partners Management
Texas
+$17.1M
5
Holocene Advisors
Holocene Advisors
New York
+$14.7M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$38.9M
2
Wells Fargo
Wells Fargo
California
-$28.3M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$23.8M
4
PCH
Polar Capital Holdings
United Kingdom
-$11.5M
5
Two Sigma Investments
Two Sigma Investments
New York
-$11.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
51
Swiss National Bank
Switzerland
$4.17M +$310K +4,000 +9%
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$3.27M +$205K +2,649 +7%
Millennium Management
53
Millennium Management
New York
$3.02M +$2.78M +35,966 New
UBS Group
54
UBS Group
Switzerland
$2.98M +$2.73M +35,241 +13,298%
RhumbLine Advisers
55
RhumbLine Advisers
Massachusetts
$2.98M +$60.5K +782 +2%
Deutsche Bank
56
Deutsche Bank
Germany
$2.94M +$91.5K +1,183 +3%
First Trust Advisors
57
First Trust Advisors
Illinois
$2.77M +$2.55M +32,932 New
Allianz Asset Management
58
Allianz Asset Management
Germany
$2.75M -$608K -7,860 -19%
Susquehanna International Group
59
Susquehanna International Group
Pennsylvania
$2.68M -$1.27M -16,458 -34%
HighTower Advisors
60
HighTower Advisors
Illinois
$2.54M +$27.6K +357 +1%
PI
61
Putnam Investments
Massachusetts
$2.54M +$2.34M +30,194 New
Morgan Stanley
62
Morgan Stanley
New York
$2.53M -$1.4M -18,087 -38%
JP Morgan Chase
63
JP Morgan Chase
New York
$2.31M +$187K +2,420 +10%
GCP
64
GSA Capital Partners
United Kingdom
$2.26M +$2.08M +26,864 New
TLP
65
Tri Locum Partners
New York
$1.99M +$1.83M +23,632 New
Tudor Investment Corp
66
Tudor Investment Corp
Connecticut
$1.95M +$1.79M +23,141 New
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
$1.92M +$1.5M +19,439 +563%
AR
68
Advisory Research
Illinois
$1.66M +$192K +2,480 +14%
SG Americas Securities
69
SG Americas Securities
New York
$1.64M +$59.8K +773 +4%
AIG
70
American International Group
New York
$1.63M -$20.9K -270 -1%
BFM
71
Boothbay Fund Management
New York
$1.6M +$481K +6,210 +48%
D.E. Shaw & Co
72
D.E. Shaw & Co
New York
$1.52M -$2.81M -36,346 -67%
CS
73
Credit Suisse
Switzerland
$1.46M +$383K +4,953 +40%
PPA
74
Parametric Portfolio Associates
Washington
$1.31M +$156K +2,014 +15%
TI
75
Trexquant Investment
Connecticut
$1.27M +$1.17M +15,061 New
1 2
3
4 5

ZNTL Hedge Fund Activity: Q4 2021 in Review

139 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Zentalis Pharmaceuticals (ZNTL) for Q4 2021, worth a combined $3.58B — up 32% from $2.71B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new ZNTL positions and 14 closed out — a net gain of 24 holders — while 53 added to existing stakes and 33 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $50.5M. The largest seller was Citadel Advisors, cutting an estimated $38.9M.

  • 139 institutional investors held Zentalis Pharmaceuticals (ZNTL) as of Q4 2021, up from 116 in Q3 2021.
  • Funds reported $3.58B of Zentalis Pharmaceuticals stock for Q4 2021, up 32% quarter-over-quarter.
  • 38 funds opened new Zentalis Pharmaceuticals positions in Q4 2021 and 14 closed out, a net change of +24 holders.
  • The largest Zentalis Pharmaceuticals buyer in Q4 2021 was T. Rowe Price Associates, an estimated $50.5M added.
  • The largest Zentalis Pharmaceuticals seller in Q4 2021 was Citadel Advisors, an estimated $38.9M sold.

Based on aggregated 13F filings for Q4 2021.